ClassID:

95301

C07D417/12 - page 3 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#601
20230202993
2023-06-29

Prodrugs of riluzole and their method of use

#602
20230202983
2023-06-29

CANNABINOID RECEPTOR MEDIATING COMPOUNDS

#603
20230201200
2023-06-29

Methods for Treating Huntington’s Disease

#604
20230192733
2023-06-22

Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus

#605
20230192678
2023-06-22

MICROBIOCIDAL DERIVATIVES

#606
20230192628
2023-06-22

MICROBIOCIDAL DERIVATIVES

#607
20230192617
2023-06-22

AZABICYCLIC(THIO)AMIDES AS FUNGICIDAL COMPOUNDS

#608
20230183229
2023-06-15

Compounds

#609
20230183207
2023-06-15

COMPOUNDS FOR THE TREATMENT OF SARS

#610
20230183188
2023-06-15

ENPP1 MODULATORS AND USES THEREOF

#611
20230180756
2023-06-15

TRIAZINE AND PYRIMIDINE (THIO)AMIDES AS FUNGICIDAL COMPOUNDS

#612
20230174540
2023-06-08

3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#613
20230174523
2023-06-08

BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF

#614
20230174488
2023-06-08

SARS-COV-2 INHIBITORS HAVING COVALENT MODIFICATIONS FOR TREATING CORONAVIRUS INFECTIONS

#615
20230167129
2023-06-01

Heterocyclic amide for inhibiting RIP1 kinase and uses thereof

#616
20230167105
2023-06-01

BCL-2 PROTEIN INHIBITORS

#617
20230167102
2023-06-01

KCNT1 INHIBITORS AND METHODS OF USE

#618
20230167101
2023-06-01

NOVEL INHIBITORS OF HISTONE ACETYLTRANSFERASE P300/CBP FOR CANCER THERAPY

#619
20230167078
2023-06-01

SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION

#620
20230167073
2023-06-01

ARYL OR HETEROARYL DERIVATIVE

#621
20230167057
2023-06-01

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#622
20230165848
2023-06-01

CHEMICAL COMPOUNDS

#623
20230159509
2023-05-25

PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF

#624
20230159493
2023-05-25

AHR AGONISTS

#625
20230159439
2023-05-25

ARYLAMIDES AND METHODS OF USE THEREOF

#626
20230157287
2023-05-25

PESTICIDAL COMPOUNDS

#627
20230150997
2023-05-18

EIF4E inhibitors and uses thereof

#628
20230150980
2023-05-18

COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF

#629
20230150979
2023-05-18

AMIDE-DISUBSTITUTED PYRIDINE OR PYRIDAZINE COMPOUNDS

#630
20230150972
2023-05-18

PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS

#631
20230150941
2023-05-18

Heterocyclic compounds for the treatment of neurological and psychological disorders

#632
20230147428
2023-05-11

BENZIMIDAZOLONE-BASED CINNAMAMIDE DERIVATIVE AS TRPV1 ANTAGONIST AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF PAIN CONTAINING SAME AS ACTIVE INGREDIENT

#633
20230147360
2023-05-11

ARYLAMIDES AND METHODS OF USE THEREOF

#634
20230147285
2023-05-11

Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease

#635
20230145835
2023-05-11

Modulators of Alpha-4-beta-7 Integrin and MAdCAM

#636
20230145071
2023-05-11

MASP-2 inhibitors and methods of use

#637
20230144767
2023-05-11

TARGETED NITROXIDE AGENTS

#638
20230143552
2023-05-11

DOPAMINE D2 RECEPTOR LIGANDS

#639
20230143250
2023-05-11

17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS OF USE THEREOF

#640
20230143059
2023-05-11

GCN2 MODULATOR COMPOUNDS

#641
20230142839
2023-05-11

N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

#642
20230142329
2023-05-11

ORGANIC LIGHT EMITTING ELEMENT

#643
20230142274
2023-05-11

SUBSTITUTED ARYL COMPOUND

#644
20230140216
2023-05-04

COMBINATION THERAPY FOR TREATING MPS1

#645
20230139936
2023-05-04

Substituted aminothiazoles as DGKzeta inhibitors for immune activation

#646
20230135350
2023-05-04

Compositions and methods for treating cancer

#647
20230134932
2023-05-04

eIF4E inhibitors and uses thereof

#648
20230134821
2023-05-04

Myc-Max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith

#649
20230132370
2023-04-27

Crystal forms of thiazole compound and application thereof

#650
20230131668
2023-04-27

HEAT SHOCK PROTEIN MODULATORS AND ANTI-HUNTINGTON DISEASE THERAPEUTIC AGENTS

#651
20230130470
2023-04-27

Aryl cyclopropyl-amino-isoquinolinyl amide compounds

#652
20230128622
2023-04-27

NOVEL FORMULATION OF MELOXICAM

#653
20230127797
2023-04-27

AHR agonists

#654
20230125667
2023-04-27

NOVEL TDZD ANALOGS AS AGENTS THAT DELAY, PREVENT, OR REVERSE AGE-ASSOCIATED DISEASES AND AS ANTI-CANCER AND ANTILEUKEMIC AGENTS

#655
20230124361
2023-04-20

SMALL MOLECULE STING ANTAGONISTS

#656
20230122024
2023-04-20

OX2R compounds

#657
20230121807
2023-04-20

Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereof

#658
20230121730
2023-04-20

Oxadiazoline compounds or salts thereof, agrohorticultural fungicides containing the compounds, and methods of using the same

#659
20230121721
2023-04-20

MONOACYLGLYCEROL LIPASE INHIBITORS

#660
20230121086
2023-04-20

RORgT INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF

#661
20230121082
2023-04-20

COMPOSITIONS AND METHODS FOR PREPARING AND USING AZETIDINES

#662
20230120211
2023-04-20

HDAC Degrader

#663
20230120169
2023-04-20

ACID ADDITION SALTS OF PIPERAZINE DERIVATIVES

#664
20230119665
2023-04-20

Cardiac sarcomere inhibitors

#665
20230119479
2023-04-20

A HISTONE DEACETYLASE INHIBITOR HAVING A NITROGEN-CONTAINING AROMATIC HETEROCYCLYL GROUP

#666
20230117425
2023-04-20

Immunomodulator compounds

#667
20230116770
2023-04-13

Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof

#668
20230116721
2023-04-13

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#669
20230115865
2023-04-13

Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for Their Preparation and Therapeutic Uses Thereof

#670
20230115270
2023-04-13

INHIBITORS OF ADRENORECEPTOR ADRAC2

#671
20230115170
2023-04-13

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#672
20230114195
2023-04-13

Benzisoxazole compound

#673
20230112832
2023-04-13

Chemokine CXCR4 Receptor Modulators and Uses Related Thereto

#674
20230111910
2023-04-13

PD-1/PD-L1 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF

#675
20230111485
2023-04-13

ORGANIC LIGHT-EMITTING DEVICE

#676
20230110928
2023-04-13

Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell

#677
20230109670
2023-04-06

Substituted bicyclic compounds as farnesoid X receptor modulators

#678
20230109505
2023-04-06

SMALL MOLECULE INHIBITORS OF SCL15A4 WITH ANTI-INFLAMMATORY ACTIVITY

#679
20230106420
2023-04-06

ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION

#680
20230103444
2023-04-06

SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER

#681
20230102081
2023-03-30

COMPOUND AS CYCLIN-DEPENDENT KINASE 9 INHIBITOR AND USE THEREOF

#682
20230100975
2023-03-30

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#683
20230100367
2023-03-30

METHODS OF TREATING CDGSH IRON SULFUR DOMAIN 2 INSUFFICIENCY-ASSOCIATED DISORDERS

#684
20230100082
2023-03-30

Human plasma kallikrein inhibitors

#685
20230099258
2023-03-30

Compounds and compositions for treating conditions associated with NLRP activity

#686
20230099151
2023-03-30

COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY AND DEGENERATIVE DISORDER

#687
20230094587
2023-03-30

Simplified structural mimetics of AIPS as quorum sensing inhibitors

#688
20230094305
2023-03-30

Human plasma kallikrein inhibitors

#689
20230092979
2023-03-23

Tripartite androgen receptor eliminators, methods and uses thereof

#690
20230092892
2023-03-23

AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS

#691
20230092163
2023-03-23

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#692
20230091528
2023-03-23

GPR84 ANTAGONISTS AND USES THEREOF

#693
20230091467
2023-03-23

FUSED RING SUBSTITUTED AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION, AND USE THEREOF

#694
20230091225
2023-03-23

Bifunctional chimeric heterocyclic compounds for targeted degradation of androgen receptors and use thereof

#695
20230089374
2023-03-23

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

#696
20230089368
2023-03-23

POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT OF MUSCLE DISEASES

#697
20230088214
2023-03-23

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

#698
20230086703
2023-03-23

N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases

#699
20230085620
2023-03-23

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#700
20230085372
2023-03-16

PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#701
20230084752
2023-03-16

ACSS2 INHIBITORS AND METHODS OF USE THEREOF

#702
20230083960
2023-03-16

Bicyclic 1,4-diazepanones and therapeutic uses thereof

#703
20230083885
2023-03-16

MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAY

#704
20230081390
2023-03-16

INHIBITORS OF RAF KINASES

#705
20230080054
2023-03-16

INHIBITORS OF ANOCTAMIN 6 PROTEIN AND USES THEREOF

#706
20230079913
2023-03-16

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

#707
20230079819
2023-03-16

COMPOUNDS AND USES THEREOF

#708
20230079631
2023-03-16

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#709
20230078764
2023-03-16

COMPOUNDS AND USES THEREOF

#710
20230078112
2023-03-16

THIADIAZOLYL DERIVATIVES

#711
20230077362
2023-03-16

MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO

#712
20230077316
2023-03-09

CTPS1 INHIBITORS AND USES THEREOF

#713
20230076435
2023-03-09

MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF

#714
20230075856
2023-03-09

CYCLIC SULFAMIDE COMPOUNDS FOR TREATMENT OF HBV

#715
20230075198
2023-03-09

Substituted indoles and methods of use thereof

#716
20230074827
2023-03-09

CRYSTALLINE FORMS OF DEUTERIUM-ENRICHED PIOGLITAZONE

#717
20230069722
2023-03-02

TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES

#718
20230069044
2023-03-02

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#719
20230065745
2023-03-02

PIPERIDINE-2,6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF

#720
20230065217
2023-03-02

Modulators of Mas-related G-protein receptor X2 and related products and methods

#721
20230063121
2023-03-02

QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS

#722
20230062975
2023-03-02

HEPATITIS B CAPSID ASSEMBLY MODULATORS

#723
20230062815
2023-03-02

Compounds and compositions for treating conditions associated with NLRP activity

#724
20230062646
2023-03-02

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#725
20230061841
2023-03-02

SHMT INHIBITORS AND USES THEREOF

#726
20230061118
2023-03-02

NEW FYN AND VEGFR2 KINASE INHIBITORS

#727
20230060004
2023-02-23

Diacylglycerol kinase modulating compounds

#728
20230059136
2023-02-23

THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#729
20230058312
2023-02-23

ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE

#730
20230057851
2023-02-23

DISPLAY INSERTS, OVERLAYS, AND GRAPHICAL USER INTERFACES FOR MULTIMEDIA SYSTEMS

#731
20230056538
2023-02-23

Human plasma kallikrein inhibitors

#732
20230053411
2023-02-23

1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES

#733
20230052191
2023-02-16

Compounds

#734
20230051130
2023-02-16

Inhibitors of NLRP3 inflammasome

#735
20230047905
2023-02-16

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#736
20230046427
2023-02-16

Methods and compounds for restoring mutant p53 function

#737
20230045421
2023-02-09

SUBSTITUTED ARYLMETHYLUREAS AND HETEROARYLMETHYLUREAS, ANALOGUES THEREOF, AND METHODS USING SAME

#738
20230044112
2023-02-09

Hepatitis b core protein modulators

#739
20230043672
2023-02-09

AROMATIC AMIDO DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS

#740
20230043400
2023-02-09

Compounds, Compositions and Methods

#741
20230043159
2023-02-09

MATRIPTASE 2 INHIBITORS AND USES THEREOF

#742
20230042881
2023-02-09

MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAY

#743
20230041563
2023-02-09

N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF

#744
20230041518
2023-02-09

Quinoline derivatives

#745
20230040299
2023-02-09

2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS

#746
20230037883
2023-02-09

Alkene-containing amide compound and application thereof

#747
20230033573
2023-02-02

Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#748
20230031406
2023-02-02

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#749
20230030414
2023-02-02

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

#750
20230028726
2023-01-26

Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#751
20230027362
2023-01-26

ISOQUINOLINONE DERIVATIVES, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING POLY(ADP-RIBOSE) POLYMERASE-1-RELATED DISEASES, COMPRISING THE SAME AS ACTIVE INGREDIENT

#752
20230026696
2023-01-26

TRPV4 RECEPTOR LIGANDS

#753
20230026425
2023-01-26

ACYLAMINO BRIDGED HETEROCYCLIC COMPOUND, AND COMPOSITION AND APPLICATION THEREOF

#754
20230025656
2023-01-26

TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF

#755
20230025630
2023-01-26

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#756
20230025510
2023-01-26

BIARYL ETHER-TYPE QUINAZOLINE DERIVATIVES

#757
20230025351
2023-01-26

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#758
20230024859
2023-01-26

Compounds and compositions for treating conditions associated with NLRP activity

#759
20230023124
2023-01-26

CANCER TREATMENTS TARGETING CANCER STEM CELLS

#760
20230021177
2023-01-19

1,2,4-triazine-4-amine derivatives

#761
20230020663
2023-01-19

SULFONAMIDE INHIBITORS AS CTPS1 INHIBITORS

#762
20230020507
2023-01-19

COMPOUND AND USE THEREOF IN TREATING AUTOIMMUNE DISEASES

#763
20230020273
2023-01-19

Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha

#764
20230019129
2023-01-19

HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS

#765
20230017637
2023-01-19

Riluzole prodrugs and their use

#766
20230017140
2023-01-19

Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease

#767
20230015617
2023-01-19

PHTHALAZINONE DERIVATIVES

#768
20230014907
2023-01-19

INHIBITORS OF APOL1 AND METHODS OF USING SAME

#769
20230013419
2023-01-19

ANALOGUES OF 3-(5-METHYL-1,3-THIAZOL-2-YL)-N-{(1R)-1-[2-(TRIFLUORO-METHYL)PYRIMIDIN-5-YL]ETHYL}BENZAMIDE

#770
20230011118
2023-01-12

Inhibitors of APOL1 and methods of using same

#771
20230010358
2023-01-12

Spiro-Sulfonamide Derivatives As Inhibitors Of Myeloid Cell Leukemia-1 (MCL-1) Protein

#772
20230010108
2023-01-12

A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP

#773
20230002356
2023-01-05

COMPOUNDS AND USES THEREOF

#774
20230002336
2023-01-05

MrgprX2 Antagonists and Uses Thereof

#775
20230002316
2023-01-05

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#776
20230000861
2023-01-05

TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) SMALL MOLECULE INHIBITOR

#777
20230000082
2023-01-05

AGROCHEMICAL COMPOUNDS

#778
20220411469
2022-12-29

COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID LINKED DOLASTATIN DERIVATIVES

#779
20220411440
2022-12-29

Glycosidase inhibitors

#780
20220411431
2022-12-29

Novel compounds and their use in therapy

#781
20220411419
2022-12-29

SMALL MOLECULE MODULATORS OF MHC-I

#782
20220411418
2022-12-29

CDGSH iron sulfur domain 2 activators and use thereof

#783
20220411417
2022-12-29

HERBICIDAL THIAZOLE COMPOUNDS

#784
20220411401
2022-12-29

Compounds for the treatment of SARS

#785
20220411390
2022-12-29

MODULATION OF BACTERIAL QUORUM SENSING WITH SYNTHETIC LIGANDS

#786
20220411385
2022-12-29

NOVEL HETEROARYL BUTANOIC ACID DERIVATIVES

#787
20220411377
2022-12-29

SELECTIVE NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS

#788
20220402906
2022-12-22

Crystal form of lanifibranor, preparation method therefor, and use thereof

#789
20220402905
2022-12-22

Anti-SARS CoV-2 inhibitors by dual viral-host targeting

#790
20220402897
2022-12-22

Chromen-4-one derivatives for the treatment and prophylaxis of hepatitis B virus disease

#791
20220402881
2022-12-22

SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS

#792
20220402875
2022-12-22

S1P3 Antagonists

#793
20220400676
2022-12-22

HERBICIDAL COMPOUNDS

#794
20220396581
2022-12-15

COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS

#795
20220396555
2022-12-15

Prodrugs of riluzole and their method of use

#796
20220396553
2022-12-15

NOVEL HYDRAZONE DERIVATIVE IN WHICH TERMINAL AMINE GROUP IS SUBSTITUTED WITH ARYL GROUP OR HETEROARYL GROUP, AND USE THEREOF

#797
20220388997
2022-12-08

COMPOUNDS FOR MODULATING ACTIVITY OF FXR AND USES THEREOF

#798
20220388967
2022-12-08

Phenyl Amino Pyrimidine Compounds and Uses Thereof

#799
20220387395
2022-12-08

UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION

#800
20220380338
2022-12-01

CYCLOALKYL 3-OXOPIPERAZINE CARBOXAMIDES AND CYCLOHETEROALKYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS

#801
20220380332
2022-12-01

PTPRD inhibitors and uses thereof

#802
20220380319
2022-12-01

SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

#803
20220380312
2022-12-01

Heteroaryl compounds as kinase inhibitor

#804
20220378951
2022-12-01

Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof

#805
20220378801
2022-12-01

NOVEL COMPOUNDS

#806
20220372028
2022-11-24

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

#807
20220372005
2022-11-24

Cycloolefin substituted heteroaromatic compounds and their use

#808
20220370371
2022-11-24

GLUTAMINASE INHIBITOR DISCOVERY AND NANOPARTICLE-ENHANCED DELIVERY FOR CANCER THERAPY

#809
20220369637
2022-11-24

PYRIDINIUM SALT AND PEST CONTROL AGENT

#810
20220363676
2022-11-17

Compounds and methods for modulating Interleukin-2-inducible T-cell kinase

#811
20220363675
2022-11-17

Novel Ferroportin Inhibitors

#812
20220363648
2022-11-17

Glucose uptake inhibitors

#813
20220363640
2022-11-17

ANTIVIRAL COMPOUNDS

#814
20220362220
2022-11-17

5-DEUTERO-THIAZOLIDINE-2,4-DIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME

#815
20220356180
2022-11-10

AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES

#816
20220356179
2022-11-10

5-membered and bicyclic heterocyclic amides as inhibitors of ROCK

#817
20220356178
2022-11-10

EIF4E inhibitors and uses thereof

#818
20220356174
2022-11-10

PYRIDIN-2-ONE COMPOUNDS USEFUL AS SMARCA2 ANTAGONISTS

#819
20220356158
2022-11-10

CGAS antagonist compounds

#820
20220356148
2022-11-10

ANTIVIRAL COMPOUNDS

#821
20220348590
2022-11-03

CYCLOOXYGENASE-2 INHIBITORS AND USES THEREOF

#822
20220348587
2022-11-03

Benzoimidazole Derivatives As Anticancer Agents

#823
20220348577
2022-11-03

CXCR4 Receptor Antagonists

#824
20220348570
2022-11-03

Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents

#825
20220348568
2022-11-03

AZETIDINYL-ACETAMIDES AS CXCR7 INHIBITORS

#826
20220340570
2022-10-27

IRAK degraders and uses thereof

#827
20220340535
2022-10-27

MCL-1 inhibitors

#828
20220332722
2022-10-20

PERK INHIBITING COMPOUNDS

#829
20220332721
2022-10-20

Muscarinic acetylcholine Mreceptor antagonists

#830
20220332709
2022-10-20

Thiophene derivatives for the treatment of disorders caused by IgE

#831
20220332705
2022-10-20

Biaryl inhibitors of Bruton's tyrosine kinase

#832
20220332697
2022-10-20

Compounds and compositions for use in treating skin disorders

#833
20220326230
2022-10-13

NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF

#834
20220324843
2022-10-13

DICARBOXYLIC ACID BISAMIDE DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS FOR PRODUCING DICARBOXYLIC ACID BISAMIDE DERIVATIVES

#835
20220324836
2022-10-13

QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS

#836
20220324835
2022-10-13

INHIBITORS OF CBL-B AND METHODS OF USE THEREOF

#837
20220324823
2022-10-13

Nootkatone derivatives and methods of using the same

#838
20220324812
2022-10-13

Inhibitors of NLRP3 inflammasome

#839
20220324811
2022-10-13

1,3-substituted cyclobutyl derivatives and uses thereof

#840
20220315574
2022-10-06

Beta-Arrestin-Modulating Compounds and Methods of Using Same

#841
20220315549
2022-10-06

HETEROAROMATIC ACETAMIDE DERIVATIVE, AND PREPARATION AND USE THEREOF

#842
20220312770
2022-10-06

PYRIDAZINOL COMPOUNDS AND DERIVATIVES, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND APPLICATIONS THEREOF

#843
20220305035
2022-09-29

HYDROXYPYRROLIDINE-SUBSTITUTED ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

#844
20220298168
2022-09-22

Compounds and uses thereof

#845
20220298151
2022-09-22

Compounds, salts thereof and methods for treatment of diseases

#846
20220298138
2022-09-22

ENZYME INHIBITORS

#847
20220298110
2022-09-22

Hepatitis B capsid assembly modulators

#848
20220289756
2022-09-15

COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF PROTEIN KINASES

#849
20220289734
2022-09-15

3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS

#850
20220289698
2022-09-15

INHIBITORS OF HUMAN ATGL

#851
20220289691
2022-09-15

5-AMINO-SUBSTITUTED PYRAZOLES AND TRIAZOLES AS PEST CONTROL AGENTS

#852
20220288069
2022-09-15

INHIBITORS OF TYROSINE KINASE

#853
20220281902
2022-09-08

MITOCHONDRIAL MODULATION TO IMPROVE METABOLIC SYNDROME DURING AGING

#854
20220281870
2022-09-08

COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENT DEVICE AND APPLICATION THEREOF

#855
20220281863
2022-09-08

COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS

#856
20220281862
2022-09-08

Imidazopyridine and oxazolopyridine derivatives and analogs thereof, methods of preparation thereof, methods of HIF-2A pathway inhibition, and induction of ferroptosis

#857
20220281833
2022-09-08

SUBSTITUTED PIPERAZINES AS SELECTIVE HDAC1,2 INHIBITORS

#858
20220281815
2022-09-08

CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS

#859
20220274977
2022-09-01

NOVEL INHIBITORS

#860
20220274976
2022-09-01

Compositions, formulations and methods for treating ocular diseases

#861
20220274970
2022-09-01

INHIBITOR COMPOUNDS

#862
20220274961
2022-09-01

SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS

#863
20220274928
2022-09-01

PAPD5 INHIBITORS AND METHODS OF USE THEREOF

#864
20220274927
2022-09-01

MEMBRANE-ACTIVE ANTI-BACTERIAL COMPOUNDS AND USES THEREOF

#865
20220272976
2022-09-01

MICROBIOCIDAL DERIVATIVES

#866
20220267312
2022-08-25

AMINO BENZOTHIAZOLE COMPOUNDS FOR TREATMENT OF ANTIBIOTIC RESISTANT BACTERIA

#867
20220267305
2022-08-25

Modulators of estrogen receptor proteolysis and associated methods of use

#868
20220267278
2022-08-25

HERBICIDAL CYCLOHEXANEDIONE DERIVATIVES

#869
20220267276
2022-08-25

NLRP MODULATORS

#870
20220259198
2022-08-18

RAD51 inhibitors

#871
20220259194
2022-08-18

Inhibiting agents for Bruton's tyrosine kinase

#872
20220256857
2022-08-18

PESTICIDAL PYRAZOLE AND TRIAZOLE DERIVATIVES

#873
20220251066
2022-08-11

SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

#874
20220251048
2022-08-11

Tead inhibitors and uses thereof

#875
20220251041
2022-08-11

1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS

#876
20220242859
2022-08-04

INHIBITORS OF SARM1

#877
20220235013
2022-07-28

2-METHYL-QUINAZOLINES

#878
20220233545
2022-07-28

ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF

#879
20220227771
2022-07-21

Androgen receptor binding molecule and use thereof

#880
20220227760
2022-07-21

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#881
20220227750
2022-07-21

METHODS AND COMPOSITIONS FOR PREVENTION OF ANAPHYLAXIS

#882
20220227749
2022-07-21

AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS

#883
20220227732
2022-07-21

Pyridine carboxamide compounds for inhibiting NAV1.8

#884
20220220122
2022-07-14

PCSK9 INHIBITORS AND METHODS OF USE THEREOF

#885
20220220097
2022-07-14

Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1

#886
20220220095
2022-07-14

N-((HETEROARYL)METHYL)-1-TOSYL-1H-PYRAZOLE-3-CARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS

#887
20220213122
2022-07-07

SUBSTITUTED 1,6-DIHYDROPYRIDINONES AND 1,2-DIHYDROISOQUINOLINONES AS BET INHIBITORS

#888
20220213088
2022-07-07

INHIBITING USP36

#889
20220213087
2022-07-07

ASPARAGINE ENDOPEPTIDASE (AEP) INHIBITORS, COMPOSITIONS, AND USES RELATED THERETO

#890
20220213086
2022-07-07

AZOLE COMPOUNDS AS IRAK INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF

#891
20220213077
2022-07-07

INHIBITORS FOR PROGRAMMED CELL NECROSIS AND PREPARATION METHOD THEREFOR AND USE THEREOF

#892
20220213069
2022-07-07

Antagonists of the muscarinic acetylcholine receptor M

#893
20220213053
2022-07-07

Thiophene derivatives as antiviral agents

#894
20220213047
2022-07-07

CARBONIC ANHYDRASE INHIBITORS FOR TREATMENT OF NEISSERIA GONORRHOEAE INFECTION

#895
20220213039
2022-07-07

Pyridinium salts and pest control agent

#896
20220211682
2022-07-07

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#897
20220211665
2022-07-07

PYRROLE AMIDE COMPOUND AND USE THEREOF

#898
20220209127
2022-06-30

Organic electric element

#899
20220204497
2022-06-30

NOVEL COMPOUND HAVING ANTICANCER ACTIVITY, AND METHOD FOR PRODUCING SAME

#900
20220204496
2022-06-30

Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]-methyl]-2,4-thiazolidinedione and salts thereof